INFINITY PHARMACEUTICALS INC - COM (INFI)

CUSIP: 45665G303

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
46,033,406
Share change
-128,236
Total reported value
$635,150,404
Put/Call ratio
96%
Price per share
$13.81
Number of holders
103
Value change
-$1,770,044
Number of buys
3
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 45665G303?
CUSIP 45665G303 identifies INFI - INFINITY PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q4 2013

As of 31 Dec 2013, INFINITY PHARMACEUTICALS INC - COM (INFI) was held by 103 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,033,406 shares. The largest 10 holders included ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT CO, FMR LLC, SAC Capital Advisors LP, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, BlackRock Fund Advisors, WELLINGTON MANAGEMENT CO LLP, State Street Corp, and BB Biotech AG. This page lists 103 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.